Catalogue
Aide
Construisez votre portefeuille ici
Saisissez la quantité à côté des actions souhaitées — votre portefeuille sera créé automatiquement.
Screener rapide : filtrez par catégorie et recommandation, consultez les fondamentaux, les métriques et les profils d’entreprise.
| Entreprise | Catégorie | Prix | Δ% | Div % | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Style | Horizon | Pot. | Risque | Recommandation | Portefeuille |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics (TXG) | Biotech | 70.11 | -14.03% | 0.0% | 6.4% | -0.59 | 0.1% | 0.0% | Croissance | Moyen | 30 | 80 | Vendre |
|
| Abivax (ABVX) | Biotech | 86.59 | -2.77% | 0.0% | 2.7% | -6.66 | -200.0% | -75.3% | Croissance | Moyen | 20 | 85 | Vendre |
|
| Alnylam Pharmaceuticals (ALNY) | Biotech | 165.00 | -5.17% | 0.0% | 2.4% | 6.10 | 10.6% | -25.8% | Croissance | Moyen | 24 | 85 | Vendre |
|
| Alvotech (ALVO) | Biotech | 4.65 | -4.91% | 0.0% | 3.1% | -0.58 | -0.1% | -109.1% | Croissance | Moyen | 32 | 71 | Vendre |
|
| Amgen (AMGN) | Biotech | 466.01 | +1.15% | 2.8% | 1.5% | 16.22 | 16.7% | 11.9% | Croissance | Moyen | 75 | 30 | Acheter |
|
| Apogee Therapeutics (APGE) | Biotech | 135.07 | 0.00% | 0.0% | 0.0% | -4.34 | 0.0% | -6.5% | Croissance | Long | 30 | 72 | Vendre |
|
| Arcus Biosciences (RCUS) | Biotech | 18.19 | -2.26% | 0.0% | 5.1% | -3.93 | 141.2% | 0.0% | Croissance | Moyen | 35 | 79 | Vendre |
|
| Arrowhead Pharmaceuticals (ARWR) | Biotech | 59.90 | -0.98% | 0.0% | 2.1% | -2.24 | 2.1% | -6.3% | Croissance | Moyen | 38 | 70 | Vendre |
|
| Atai Life Sciences (ATAI) | Biotech | 7.35 | 0.00% | 91.8% | 0.0% | -2.90 | 78.6% | 15.6% | Croissance | Moyen | 70 | 60 | Conserver |
|
| Bio-Techne (TECH) | Biotech | 72.66 | -0.07% | 0.6% | 0.1% | 1.17 | 3.1% | 0.2% | Croissance | Moyen | 65 | 40 | Acheter |
|
| BioCryst Pharmaceuticals (BCRX) | Biotech | 8.47 | -0.59% | 0.0% | 2.4% | -1.44 | 39.5% | 0.0% | Croissance | Moyen | 55 | 70 | Conserver |
|
| Biogen (BIIB) | Biotech | 253.62 | +1.59% | 0.0% | 2.0% | 150.30 | 2.5% | 17.0% | Croissance | Moyen | 73 | 33 | Acheter |
|
| Biohaven (BHVN) | Biotech | 15.42 | -6.49% | 0.0% | 6.6% | -4.64 | 0.0% | -19.6% | Croissance | Moyen | 62 | 66 | Conserver |
|
| BioMarin Pharmaceutical (BMRN) | Biotech | 58.51 | +1.77% | 0.0% | 1.6% | 0.38 | 29.2% | 26.7% | Croissance | Moyen | 64 | 45 | Conserver |
|
| BioNTech (BNTX) | Biotech | 88.17 | -1.08% | 0.0% | 2.4% | -6.73 | -12.0% | -54.3% | Croissance | Moyen | 30 | 73 | Vendre |
|
| CAMP4 Therapeutics (CAMP) | Biotech | 3.96 | +1.54% | 0.0% | 4.3% | -2.23 | 37.5% | -174.3% | Croissance | Moyen | 38 | 72 | Vendre |
|
| Celcuity (CELC) | Biotech | 69.13 | -0.25% | 0.0% | 3.6% | -4.29 | 0.0% | -24.1% | Croissance | Moyen | 30 | 76 | Vendre |
|
| Cidara Therapeutics (CDTX) | Biotech | 221.38 | 0.00% | 0.0% | 0.0% | -11.78 | 0.0% | 0.0% | Croissance | Moyen | 20 | 80 | Vendre |
|
| Corcept Therapeutics (CORT) | Biotech | 81.12 | -5.62% | 0.0% | 4.8% | 0.52 | 55.3% | 1383.3% | Croissance | Moyen | 35 | 71 | Vendre |
|
| Corvus Pharmaceuticals (CRVS) | Biotech | 10.03 | -1.96% | 0.0% | 3.3% | -0.64 | 0.0% | -19.4% | Croissance | Moyen | 21 | 79 | Vendre |
|
| Crinetics Pharmaceuticals (CRNX) | Biotech | 84.95 | 0.00% | 0.0% | 0.0% | -5.05 | 134.0% | 0.0% | Croissance | Moyen | 70 | 69 | Conserver |
|
| Definium Therapeutics (DFTX) | Biotech | 36.33 | -4.29% | 0.0% | 3.3% | -3.44 | 0.0% | -166.2% | Croissance | Moyen | 39 | 72 | Vendre |
|
| Dianthus Therapeutics (DNTH) | Biotech | 82.38 | -0.39% | 0.0% | 2.6% | -0.13 | 64.4% | 0.0% | Croissance | Long | 39 | 70 | Vendre |
|
| Disc Medicine (IRON) | Biotech | 80.84 | -2.41% | 0.0% | 8.9% | -6.60 | 0.0% | 9.9% | Croissance | Moyen | 72 | 63 | Conserver |
|
| Forte Biosciences (FBRX) | Biotech | 76.99 | 0.00% | 0.0% | 0.0% | -4.59 | 0.0% | 10.2% | Croissance | Moyen | 70 | 61 | Conserver |
|
| Illumina Inc. (ILMN) | Biotech | 235.99 | -18.64% | 0.0% | 4.8% | 5.89 | -2.6% | 6.5% | Croissance | Long | 34 | 80 | Vendre |
|
| ImmunityBio (IBIO) | Biotech | 0.77 | -5.52% | 0.0% | 4.9% | -0.33 | -100.0% | 42.3% | Croissance | Moyen | 25 | 85 | Vendre |
|
| Immunovant (IMVT) | Biotech | 29.17 | -1.59% | 0.0% | 2.4% | -2.82 | 0.0% | -19.3% | Croissance | Moyen | 30 | 72 | Vendre |
|
| Insmed (INSM) | Biotech | 112.58 | +0.89% | 0.0% | 1.5% | -4.11 | 39.1% | 91.1% | Croissance | Moyen | 64 | 65 | Conserver |
|
| Intellia Therapeutics (NTLA) | Biotech | 12.47 | -5.74% | 0.0% | 3.2% | -3.36 | -49.1% | -0.1% | Croissance | Moyen | 49 | 73 | Conserver |
|